Open to Debate cover image

Is the FDA Too Cautious?

Open to Debate

00:00

The FDA's Precautionary Approach to Drug Approval

Peter Lorry: FDA at this point is more or less gotten at right, and you'll hear some criticisms from me. But when we talk about caution, let's at least unpack the question. Are we talking about caution as in too fast or not fast enough? And I would submit that FDA is not too cautious with respect to either of these.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app